Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI
Crossref DOI link: https://doi.org/10.1007/s12032-014-0063-z
Published Online: 2014-06-24
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Rong-Hang
Shi, Sheng-Bin
Qi, Jie-Lin
Tian, Jing
Tang, Xiao-Yong
Liu, Guo-Fang
Chang, Chun-Xiao
Text and Data Mining valid from 2014-06-24